The Form 144 signals continued selling by a top pre-IPO holder. Given the small market cap and recent insider sales pattern, this likely weighs on sentiment. Traders should watch for follow-through on the sale and monitor any subsequent Form 4 filings. The absence of a positive catalyst from the company's pipeline (no cross-filing context) amplifies the bearish read.
Price Chart
Executive Summary
MPM Oncology Innovations Fund, a major insider, filed a Form 144 notice of intent to sell 23,248 shares of Werewolf Therapeutics (HOWL) with an approximate market value of $7,509 as of the filing date. The selling entity is a large pre-IPO venture investor. The filing signals a planned exit by a significant holder, which is a bearish signal given the company's small $16M market cap and the 30-day insider selling pattern of $598K.
Key Facts
- MPM Oncology Innovations Fund L.P. filed Form 144 to sell 23,248 shares of HOWL common stock.
- Approximate value of proposed sale: $7,509 based on filing date (06/29/2026).
- Shares were acquired on 05/04/2021 via private placement from the issuer.
- The filing notes securities sold over the last 3 months, indicating prior selling.
- Recent insider activity (30 days) shows 10 sales totaling $598K.
- HOWL market cap is approximately $16M.
- There is no cross-filing context provided.
Financial Impact
Approximately $7,509 proposed sale by a major venture investor, representing a small portion of total holdings but significant given the company's $16M market cap.
Risk Factors
- Form 144 is an intent to sell; the sale may not be executed, but the signal is negative.
- Continued insider selling could indicate lack of confidence or a liquidity-driven exit by early investors.
- The company is a pre-revenue biotech with limited cash runway, making any insider sale more impactful.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001628280-26-046087 |
| Document: 0001628280-26-046087-index.html | 0001628280-26-046087 |
| Document: 0001628280-26-046087.txt | 0001628280-26-046087 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | S-4/A | $0.9806 | awaiting T+5 | — | $1.04 (−6.06%) |
Sep 22, 2026 4w ago | S-4 | $0.9894 $0.9223 | ▲ +6.78% | ▲ +6.11% | $1.04 (−5.11%) |
Sep 21, 2026 5w ago | SC 13G | $0.9800 $0.9300 | ▼ −5.10% | ▼ −4.08% | $1.04 (+6.12%) |
Aug 21, 2026 9w ago | 425 | $0.8740 $0.9433 | ▲ +7.93% | ▲ +7.46% | $1.04 (+18.99%) |
Aug 21, 2026 9w ago | 8-K | $0.8740 $0.9433 | ▲ +7.93% | ▲ +7.46% | $1.04 (+18.99%) |
Aug 21, 2026 9w ago | Press Release | $0.8740 $0.9433 | ▼ −7.93% | ▼ −7.46% | $1.04 (−18.99%) |
Jul 31, 2026 12w ago | 8-K | $0.3531 $0.3971 | ▲ +12.46% | ▲ +8.95% | $1.04 (+194.53%) |
Jul 31, 2026 12w ago | Press Release | $0.3531 $0.3971 | ▲ +12.46% | ▲ +8.95% | $1.04 (+194.53%) |
Jun 29, 2026 17w ago | 144 | $0.3599 $0.3200 | ▲ +11.09% | ▲ +11.69% | $1.04 (−188.97%) |
Jun 29, 2026 17w ago | 144 | $0.3599 $0.3200 | ▲ +11.09% | ▲ +11.69% | $1.04 (−188.97%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers